Aluroderm Scar Patch

Manufacturer
Asclemed USA, Inc. | ASCLEMED USA INC. DBA ENOVACHEM
Effective date
2025-04-01
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 00:58:26

Label at a glance#

ProductAluroderm Scar
Active ingredientALLANTOIN
Label structure14 sections

Indications and uses

-Scar Management -Temporarily protects and helps relieve chapped or cracked skin

Dosage and administration

Adults and Children 12 Years of Age and Older -Clean and dry the affected area -Apply as needed

Label contents#

Full prescribing information#

ACTIVE INGREDIENTS

OTC - ACTIVE INGREDIENT SECTION

Allantoin 0.75%

PURPOSE

OTC - PURPOSE SECTION

Skin Protectant

USES

INDICATIONS & USAGE SECTION

-Scar Management

-Temporarily protects and helps relieve chapped or cracked skin

WARNINGS

WARNINGS SECTION

FOR EXTERNAL USE ONLY

DO NOT USE

OTC - DO NOT USE SECTION

-On deep punctures, serious burns, or infected skin

WHEN USING THIS PRODUCT

OTC - WHEN USING SECTION

Avoid contact with the eyes

STOP USE AND ASK DOCTOR IF

OTC - STOP USE SECTION

-Condition worsens

-Excessive skin irritation develops

-Condition persists for more than 7 days, or condition clears up and occurs again within 3 days

IF PREGNANT OR BREASTFEEDING

OTC - PREGNANCY OR BREAST FEEDING SECTION

Consult a physician before use

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If ingested, seek medical help or contact Poison Control immediately

DIRECTIONS

DOSAGE & ADMINISTRATION SECTION

Adults and Children 12 Years of Age and Older

-Clean and dry the affected area

-Apply as needed

OTHER INFORMATION

SPL UNCLASSIFIED SECTION

-Store at room temperature

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

Hyaluronic Acid, Taxifolin, Polyurethane, Sodium Carboxymethyl Cellulose

QUESTIONS OR COMMENTS

SPL UNCLASSIFIED SECTION

info@olakinotherapeutics.com

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Relabeled by:

Enovachem PHARMACEUTICALS

Torrance, CA 90501

labellabel

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
2711688allantoin 0.75 % Medicated PatchPSN1
2711688allantoin 0.0075 MG/MG Medicated PatchSCD1
2711688allantoin 0.75 % Medicated PatchSY1

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
76420-955-01Aluroderm Scar1 in 1 BOXPATCH11
76420-955-01Aluroderm Scar5 in 1 POUCHPATCH51

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
76420-955ALURODERM SCAR (ALLANTOIN) PATCH [ASCLEMED USA, INC.]1Current NDC, 2 package rows20250403_60656ca1-5218-4595-854e-19f1061def1e.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
84991-0316-1EA - Each84991-0316b16dde49-d6b5-4fb3-b54d-a484f7ce4e6212025-03-04

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
76420-95576420-955-01
84991-0316

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Aluroderm ScarALLANTOINAsclemed USA, Inc.60656ca1-5218-4595-854e-19f1061def1e2025-04-01WarningsExact identifier
ndc (package): 76420-955-01
ndc (product): 76420-955
ndc11 (package): 76420095501
spl id: 31b18752-52bd-1354-e063-6394a90a31f1
spl set id: 60656ca1-5218-4595-854e-19f1061def1e
Aluroderm ScarALLANTOINOlakino Therapeutics LLC2a848dde-8fc4-ab10-e063-6294a90a25832025-02-07WarningsExact identifier
ndc (product): 84991-0316

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.